Physicians warned about counterfeit medical devices

July 24, 2014
Physicians warned about counterfeit medical devices
Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in Surgery and Medicine.

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in Surgery and Medicine.

Brian S. Biesman, M.D., from the Nashville Center for Laser and Facial Surgery in Tennessee, and Neelam Patel, from the Vanderbilt University School of Medicine in Nashville, discuss the prevalence and dangers of counterfeit medical devices, many of which target legitimate devices manufactured by Zeitiq and Ulthera.

The researchers note that both companies' devices are protected by patents and have integrated safety features. However, the counterfeit devices are not certified as safe, reliable, or reproducible, and numerous injuries have been documented with their use. There may be economic incentives for purchasing counterfeit devices, but these are outweighed by the risks and liabilities associated with using counterfeit technology. Medical malpractice insurance carriers may not provide coverage for litigation arising from use of non-U.S. Food and Drug Administration-approved devices. There are currently 29 imitations of the Zeltiq device and at least five counterfeit Ulthera devices. Despite being unregulated and unapproved, these can be purchased via the Internet and some are displayed at legitimate trade shows.

"Physicians should be aware of the existence and prevalence of counterfeit and need to understand that use of these devices in the United States can lead to severe economic, civil, and criminal penalties," the authors write.

One author disclosed financial ties to Zeltiq and Ulthera.

Explore further: FDA warns doctors of counterfeit Botox

More information: Full Text

Related Stories

FDA warns doctors of counterfeit Botox

December 24, 2012
Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.

Roche warns of counterfeit cancer drug in US

February 14, 2012
(AP) -- The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S.

FDA: Purveyors of phony botox targeting U.S. practices

April 29, 2013
(HealthDay)—Medical practices that purchase Botox may unwittingly be purchasing a fraudulent product not approved by the U.S. Food and Drug Administration for sale in the United States, according to an April 26 drug safety ...

Fake Avastin contained several chemicals, no drug

February 28, 2012
(AP) -- Counterfeit versions of the popular cancer drug Avastin obtained by European regulators contain a variety of chemicals, but not the active ingredient found in the genuine drug, according to drugmaker Roche.

Fake drug sales are increasing on the Internet and turning up in legitimate supply chains

February 22, 2012
Criminal gangs are increasingly using the internet to market life-threatening counterfeit medicines and some have even turned up in legitimate outlets such as pharmacies, according to a review led by Dr Graham Jackson, editor ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.